ADVERTISEMENT

Motilal Oswal: Robust India Sales, Better Operating Leverage Drive Cipla’s Q1 Earnings 

Motilal Oswal: Robust India Sales, Better Operating Leverage Drive Cipla’s Q1 Earnings

Vaccine vials enter the conveyor of a machine during inspection and screening for defects at the Serum Institute of India Ltd. pharmaceutical plant in Pune, Maharashtra(Photographer Sanjit Das/Bloomberg)
Vaccine vials enter the conveyor of a machine during inspection and screening for defects at the Serum Institute of India Ltd. pharmaceutical plant in Pune, Maharashtra(Photographer Sanjit Das/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More